One of the most substantial requirements for drug and drug carriers is to have either no or low levels of intrinsic cytotoxicity. To evaluate cytotoxicity, the cell culture system has been frequently used, e.g. a dye exclusion assay, 51 Cr release assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, lactate dehydrogenase (LDH) assay and 3 H-thymidine uptake assay. Studies with isolated red blood cells (RBC), which have no nucleus, mitochondria, endoplasmic reticulum, or other organelles, may provide simple and reliable information to classify the drug and drug carriers according to their cytotoxicity because the interaction of drugs and drug carriers with plasma membranes must be the initial step of cell damage.
Cr release assay, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, lactate dehydrogenase (LDH) assay and 3 H-thymidine uptake assay. Studies with isolated red blood cells (RBC), which have no nucleus, mitochondria, endoplasmic reticulum, or other organelles, may provide simple and reliable information to classify the drug and drug carriers according to their cytotoxicity because the interaction of drugs and drug carriers with plasma membranes must be the initial step of cell damage. 1) Lipid rafts are dynamic assemblies of proteins and lipids that float freely within the liquid-disordered bilayer of cellular membranes but can also cluster to form larger, ordered platforms. [2] [3] [4] Lipid rafts are mainly composed of cholesterol and sphingolipids such as sphingomyelin in the cell membranes. 5, 6) Recently, it is thought that lipid rafts on cell membranes have heterogeneity such as cholesterol-rich microdomains and sphingolipids-rich microdomains. [7] [8] [9] [10] In addition, lipid rafts contain proteins involved in the regulation of actin rearrangement, and the actin cytoskeleton has crucial role in inducing and sustaining rafts polarization in cells. 9) Cyclodextrins (CyDs) and their hydrophilic derivatives form inclusion complexes with hydrophobic molecules. CyDs can improve the solubility, dissolution rate and bioavailability of the drugs, and so the widespread use of CyDs is well known in the pharmaceutical field. 12, 13) CyDs have been reported to interact with cell membrane constituents such as cholesterol and phospholipids, resulting in the induction of hemolysis of human and rabbit RBC. [14] [15] [16] Additionally, methyl-b-cyclodextrin (M-b-CyD) is acknowledged to disrupt the structures of lipid rafts and caveolae, 17, 18) which are lipid microdomains formed by lateral assemblies of cholesterol and sphingolipids in the cell membrane, through extraction of cholesterol from the microdomains. 19) We previously reported that a-CyD, b-CyD and g-CyD, which are composed of 6, 7 and 8 glucose units, induce morphological changes in erythrocytes from discocyte to stomatocyte and hemolysis at higher concentrations. 20) The magnitude of hemolytic activity of the CyDs was reported to increase in the order of g-CyDϽa-CyDϽb-CyD. 14, 20) Recently, various hydrophilic CyD derivatives have been developed to improve aqueous solubility and the complexation ability of the CyDs. Of various hydrophilic CyD derivatives, hydroxypropylated CyDs, sulfobutyl ether CyDs and branched CyDs have been demonstrated to have lesser hemolytic activities than the CyDs. 21) More recently, we revealed that 2,6-di-O-methyl-a-CyD (DM-a-CyD) has higher hemolytic activity and morphological change ability from discocyte to stomatocyte than a-CyD and 2-hydroxypropyla-CyD (HP-a-CyD), probably through the extraction of phospholipids including sphingomyelin and proteins, not cholesterol, from the sphingolipid-rich lipid rafts of RBC membranes. 22) In addition, the methylation of the hydroxyl group of a glucopyranose unit of b-CyD such as M-b-CyD and 2,6-di-O-methyl-b-cyclodextrin (DM-b-CyD), is known to show higher hemolytic activity through the extraction of cholesterol from RBC membrane. 12) However, the effects of M-b-CyD and DM-b-CyD on morphological changes are still unknown. In the present study, we compared the effects of M-b-CyD and DM-b-CyD on hemolysis and morphological changes in rabbit RBC (RRBC) with those of b-CyD, and examined the involvement of lipid rafts of RRBC membranes in the effects of these b-CyDs on the morphological changes of RRBC.
MATERIALS AND METHODS
Materials b-CyD and DM-b-CyD were donated from Nihon Shokuhin Kako (Tokyo, Japan). M-b-CyD (average degree of substitutionϭ10.5-14.7 per 7 glucose units) was purchased from Sigma (St. Louis, MO, U.S.A.). b-CyD and DM-b-CyD were used after recrystallization with water and methanol, respectively. N-6-((N-(7-Nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-hexanoil) sphingosylphosphocholine (NBD-sphingomyelin) was purchased from Invitrogen (Carlsbad, CA, U.S.A.). All other chemicals and solvents were of analytical reagent grade.
Hemolytic Activity RRBC were isolated from Japanese white male rabbits (Kyudo, Tosu, Japan) as described previously. 18, 21) Isolated RRBC were centrifuged at 1000ϫg for 5 min and washed three times with 10 mM phosphatebuffered saline (PBS, pH 7.4). Five percents of RRBC suspension in PBS were incubated with 2 ml of PBS (pH 7.4) containing b-CyDs for 30 min at 37°C. After centrifugation at 1000ϫg for 10 min, the optical density of the supernatant was measured at 543 nm. Results were expressed as a percent of total hemolysis, which was obtained when RRBC were incubated in water only. All hemolytic assays were carried out on the same day of blood collection.
Scanning Electron Microscopy (SEM) The observation of RRBC with SEM was carried out as reported previously. 20) RRBC were treated with b-CyDs using the same methods as used for hemolytic assay. After fixation of samples with 2% (w/v) glutaraldehyde at 25°C for 30 min, RRBC were resuspended with distilled water. After samples were dried at 25°C for overnight, they were sputtered with gold (5 min, 6-8 mA) using an Ion Coater IB-3 (EIKO Engineering, Ibaraki, Japan) and observed with a Hitachi S-510 SEM (Hitachi, Tokyo, Japan) at an accelerating voltage of 8-15 kV.
Assay of Phospholipids, Cholesterol and Total Proteins Released from RRBC to Supernatant After RRBC were incubated with b-CyDs at onset concentrations of hemolysis, i.e. 3 mM, 1 mM and 0.8 mM for b-CyD, M-b-CyD and DMb-CyD, respectively, for 30 min, the RRBC suspension was centrifuged at 1000ϫg for 10 min. The resulting supernatant (1.5 ml) was mixed with 3 ml of chloroform/methanol (15 : 2, v/v). After shaking for 10 min, the phase of chloroform was recovered and evaporated to concentrate membrane components. The concentrations of phospholipids and cholesterol in supernatants were determined using a Phospholipids-test Wako ® and Cholesterol-test Wako ® (Wako Pure Chemical Industries, Osaka, Japan), respectively. Total phospholipids and cholesterol in RRBC were extracted according to the method reported by Bligh and Dyer. 24) The concentration of total proteins released from RRBC to the supernatants was determined with the Bradford protein assay method.
Purification of Low-Density Membrane Domain of RRBC Low-density lipid raft-enriched domains were isolated as described previously.
2) Sphingolipid-rich lipid rafts on RRBC were labeled with NBD-sphingomyelin according to the method reported by Dekkers et al. 25) In brief, 2 ml of rabbit blood was incubated with 12.5 mg/ml of NBD-sphingomyelin at 4°C for 30 min. The blood was centrifuged at 1000ϫg for 5 min and the pellet was washed three times with cold PBS. Two millilitres of the b-CyDs solution were added to 1 ml of the RRBC suspension. After further incubation at 4°C for 30 min, RRBC were lysed with 1% (w/v) Triton X-100 at 4°C for 10 min. After centrifugation at 10000ϫg for 10 min, pellet was resuspended with 2 ml of 0.5 M sodium carbonate (pH 11) and homogenized extensively using a Potter-elvehjem type homogenizer (10 strokes), a Polytron tissue grinder and a sonicator. The resulting homogenate was brought to 45% (w/v) sucrose solution by the addition of 2 ml of 90% (w/v) sucrose in MESbuffered saline (MBS; 25 mM MES, pH 6.5, 150 mM NaCl) and overlaid with two layers of 35% (w/v) and 5% (w/v) sucrose solution in MBS containing 0.25 M carbonate (4 ml each). The gradient was then centrifuged at 200000ϫg for 18 h using a Beckman OptimaTM L-70K with a Beckman SW41Ti rotor (Palo Alto, CA, U.S.A.). For the analysis of the resulting gradient, 12 fractions (each 1 ml) were collected from the top to the bottom of the gradient. The 4-6 fractions and 9-11 fractions were pooled as low-density and high-density membrane fractions, respectively. Fluorescent intensity of NBD-sphingomyelin was determined by a Hitachi F-4500 spectrofluorometer (Tokyo, Japan) at 25°C. The excitation and emission wavelengths were 466 nm and 536 nm, respectively. The concentrations of total proteins in low-and high-density fractions were determined by Bradford protein assay kit (Bio-Rad Laboratories, Tokyo, Japan).
Flow Cytometry A hundred microlitres of rabbit blood were added to 900 ml of PBS and then incubated with 5 mg/ml of NBD-sphingomyelin at 4°C for 30 min. The blood was centrifuged at 1000ϫg for 5 min and the pellet was washed with PBS. The b-CyDs solutions were added to the resulting NBD-labeled RRBC suspension at various concentrations. After further incubation at 4°C for 30 min, RRBC were resuspended in HBSS and quantified using a FACSCalibur flow cytometer with CellQuest software (Becton Dickinson, Mountain View, CA, U.S.A.).
Statistical Analysis Data are given as the meanϮS.E. Statistical significance of means for the studies was determined by analysis of variance followed by Scheffe's test. pvalues for significance were set at 0.05. Effects of Methylated b b-CyDs on Morphological Changes of RRBC Sheets and Singer proposed bilayer couple hypothesis, briefly, two types of morphological changes of erythrocytes, echinocyte (or crenation) and stom-atocyte (or invagination), were caused by charged amphiphipaths due to intercalation into one side of lipid bilayer. 26) We previously reported that not only unmodified CyDs but also DM-a-CyD induce stomatocyte in human and rabbit erythrocytes due to the interaction with membrane components. 14, 20, 22) Hence, we investigated which type of morphological changes was induced by M-b-CyD and DMb-CyD in RRBC. Five percents of RRBC suspensions with PBS were incubated with b-CyDs for 30 min at 37°C. After fixation of RRBC by glutaraldehyde, samples were observed with a SEM. RRBC treated with 3 mM b-CyD showed morphological change from discocyte to stomatocyte (Fig. 2B) . 14,21) In general, the side chain of cholesterol preferably included into the hydrophobic cavity of b-CyD, whereas the acyl chain of phospholipids fits tightly into the a-CyD cavity and more loosely into the larger inner space of b-and gCyDs. Among the three unmodified CyDs, g-CyD has the least lipid selectivity. 27) To gain insight into the mechanism for hemolysis and morphological changes induced by methylated b-CyDs, the effects of M-b-CyD and DM-b-CyD on release of membrane components from RRBC were investigated. After treatment of RRBC with b-CyDs, the concentrations of phospholipids and cholesterol released in the supernatants were determined using the corresponding assay kits. At the pre-hemolytic concentrations of b-CyDs, DM-b-CyD significantly released phospholipids from RRBC, compared to b-CyD and M-b-CyD (Fig. 3A) . Meanwhile, the three of b-CyDs markedly released cholesterol from RRBC to supernatants, but M-b-CyD and DM-b-CyD showed the property to extract cholesterol more than unmodified b-CyD (Fig.   3B ). Interestingly, DM-b-CyD released phospholipids more than M-b-CyD even though cholesterol extraction abilities of DM-b-CyD and M-b-CyD were almost the same. In addition, we also confirmed that M-b-CyD and DM-b-CyD released proteins from RRBC to supernatants much more that b-CyD (Fig. 3C) . Taken together, these results suggest that the effects of b-CyDs to release membrane components from RRBC are associated with the magnitude of hemolytic activity of b-CyDs.
RESULTS

Hemolytic
Effects of Methylated b b-CyDs on the Extent of Proteins and Sphingomyelin in Lipid Rafts of RRBC Recently, it is thought that lipid rafts on cell membranes have heterogeneity such as cholesterol-rich microdomains and sphingolipids-rich microdomains. [7] [8] [9] [10] We previously reported that DM-b-CyD significantly impaired the function of P-glycoprotein (P-gp), through the extraction of these transporters via cholesterol-depletion in caveolae. 28, 29) In addition, Irie and Uekama et al. demonstrated that unmodified CyDs extracted membrane proteins such as band 3 and band 4, which are well known as spectrin-interacting proteins to maintain the shape and elasticity of RRBC, from erythrocyte membranes. 27) To gain insight into the mechanism of morphological change in RRBC by methylated b-CyDs, we therefore examined the effects of M-b-CyD and DM-b-CyD on the amounts of proteins and sphingomyelin in lipid rafts of RRBC.
At first, we determined the amount of proteins in low-density membrane domains as the lipid raft fractions which were purified from RRBC treated with methylated b-CyDs by a sucrose gradient centrifugation (Fig. 4A) . Both M-b-CyD and DM-b-CyD reduced the amount of proteins with some significance in the low-density fraction, compared to control (non-treated) at the pre-hemolytic concentrations. Meanwhile, b-CyD did not affect the amount of proteins in lowdensity fraction. Here only DM-b-CyD, not M-b-CyD, extracted proteins from the high-density fraction purified as the non-lipid raft fractions (Fig. 4B) . These results suggest that morphological changes in RRBC from discocyte to echinocyte induced by M-b-CyD and DM-b-CyD may be resulting from extraction of membrane proteins from lipid rafts.
Next, we determined the amount of NBD-sphingomyelin in lipid rafts using a fluorescent spectrometer (Fig. 5A) . The NBD-sphingomyelin labeled in RRBC membranes was predominantly localized in low-density membrane fractions, suggesting the labeling of NBD-sphingomyelin in sphingolipid-rich lipid rafts. The treatment of RRBC with 0.8 mM DM-b-CyD significantly lowered the amount of NBD-sphingomyelin in the low-density membrane fractions compared to control, but the lowering effects of M-b-CyD were only slight (Fig. 5A) . Next, we measured the amount of NBDsphingomyelin of cell surface after treatment with b-CyDs with a flow cytometer (Fig. 5B) . The curves corresponding to NBD-sphingomyelin were shifted in the order of b-CyDϽM-b-CyDϽ ϽDM-b-CyD. These results suggest that DM-b-CyD may interact with sphingolipids-rich lipid rafts only slightly during the morphological changes in RRBC.
DISCUSSION
In the present study, we revealed that M-b-CyD and DMb-CyD have hemolytic activity stronger than b-CyD, and induce morphological changes in RBC from discocyte to echinocyte, different from the morphological change to stomatocyte induced by b-CyD, possibly due to extraction of both cholesterol and membrane proteins from cholesterolrich lipid rafts of RRBC membranes.
It is evident that hemolytic activity of the three b-CyDs used in this study could be associated with the ability of bCyD to extract cholesterol from RRBC membranes. Hemolytic activity of b-CyDs in erythrocytes is acknowledged to increase in the order of HP-b-CyDϽb-CyDϽDM-b-CyD, consistent with the magnitude of the ability of b-CyDs to extract cholesterol. 21) In the present study, we clarified that hemolytic activity of DM-b-CyD and M-b-CyD was higher than b-CyD, consistent with the abilities of DM-b-CyD and M-b-CyD to release cholesterol and proteins from RRBC membranes (Figs. 1, 3, 4) . These results suggest that hemolytic activity of b-CyDs is involved in extraction of cholesterol and proteins from RRBC membranes. Additionally, it is assumed that the different hemolytic activity of DM-bCyD and M-b-CyD could be ascribed to the distinct solubilizing effects of membrane lipids through the different position and/or degree of substitution of methyl group and their surface tension.
It is well known that RRBC show various shape changes depending on the set of agents including amphiphilic drugs, salt, pH, ATP and cholesterol. The first explanation of these shape changes in RRBC was provided by Sheetz and Singer as bilayer couple hypothesis. 26) This hypothesis explains that mechanism of shape changes in RRBC induced by charged amphiphilic agents is based on the different environment between the outer and inner leaflets of lipid bilayers. However, it is highly improbable that the morphological changes in RRBC from discocyte to echinocyte induced by M-b-CyD and DM-b-CyD can be simply explained by the hypothesis, because 1) the methylated b-CyDs used in this study have no charge, 2) CyDs were unable to penetrate into cell membranes because of their high molecular mass and hydrophilicity. 12, 27) Meanwhile, the previous reports demonstrated that changes in the ratio of cholesterol/phospholipids or distribution of membrane components affect membrane deformability. [30] [31] [32] As a result, we clarified here that M-b-CyD and DM-b-CyD significantly extracted cholesterol rather than phospholipids from RRBC membranes to the supernatant (Fig. 3) , resulting in inhomogeneous rigidity in RRBC membranes followed by RRBC deformation. Therefore, these results suggest that morphological changes in RRBC induced by the b-CyDs may be caused by altering the ratio of cholesterol/phospholipids in lipid bilayers of RRBC membranes.
A question that remains is why M-b-CyD and DM-b-CyD induced the morphological change to echinocyte, despite bCyD induced the change to stomatocyte because all of the b-CyDs used here dominantly extracted cholesterol from RRBC membranes. The detailed mechanism remains unclear, but two possibilities can be considered. One possibility is that the amounts of cholesterol released from RRBC after treatment with b-CyDs are involved in the different morphological change because these effects of M-b-CyD and DM-bCyD were higher than that of b-CyD. However, the difference of these effects between methylated b-CyDs and b-CyD were not statistically significant under the present experimental conditions. Therefore, this possibility may be excluded. Another possibility is that the reduction of proteins in lipid rafts from RRBC membranes might be involved in the difference in the morphological changes. In the present study, we revealed that M-b-CyD and DM-b-CyD reduced the extent of proteins in lipid rafts of RRBC membranes (Fig. 4) . Additionally, the abilities of M-b-CyD and DM-b-CyD to release total proteins from RRBC membranes into supernatant were strikingly higher than that of b-CyD (data not shown). Furthermore, we reported that DM-b-CyD, but not b-CyD, releases P-gp from lipid microdomains of the apical membranes of Caco-2 cell monolayers through cholesterol extraction from the microdomains. 28, 33) Thus, the effects of DM-bCyD and M-b-CyD on the protein extraction from RRBC are likely to be stronger than b-CyD. It is acknowledged that spectrin and spectrin-interacting proteins such as ankyrin, band 3, band 4 and NCAM120 maintain the shape and elasticity of RRBC. [34] [35] [36] [37] [38] [39] [40] [41] [42] Regarding the effects of unmodified CyDs on cytoskeletal proteins in RRBC, Irie and Uekama et al. 27) demonstrated that b-CyD preferentially extracted bands 5 and 6 from erythrocytes, but it did bands 3 and 4 to a lesser extent. It should be noted that not only band 3 is a lipid rafts protein but also spectrin, actin and protein 4.2 are partly associated with the lipid rafts in the RBC membranes. 43) Taken together, these several lines of evidence suggest that M-bCyD and DM-b-CyD, unlikely b-CyD, release these lipid rafts-enriched proteins from the RRBC membranes, resulting in the morphological change of RRBC toward echinocyte through altering lipid-protein interaction in cholesterol-rich lipid rafts of RRBC. Further studies are needed to identify of proteins extracted from RRBC membranes treated with methylated b-CyDs on using a proteomics technique and also to clarify the relationship between morphological changes of RRBC and the amounts of membrane components released from RRBC membranes after treatment with these b-CyDs.
Lipid rafts have been identified to have heterogeneity such as cholesterol-rich microdomains and sphingolipids-rich microdomains. [7] [8] [9] [10] In addition, the widespread use of M-bCyD to change the structure and the function of lipid rafts has been well known. 4, 18) As described above, M-b-CyD and DM-b-CyD induced morphological changes of RRBC from discocyte to echinocyte (Fig. 1) and significantly extracted cholesterol rather than phospholipids from RRBC membranes to the supernatant, e.g. in the case of DM-b-CyD, the percents of cholesterol and phospholipids released from RRBC membranes were approximately 90% and 17%, respectively (Fig. 3) . These results suggest that M-b-CyD and DM-b-CyD dominantly interact with lipid rafts. Moreover, we revealed that DM-a-CyD lowered the amount of sphingomyelin in sphingolipids-rich lipid rafts and induced morphological change in stomatocyte in RRBC. 22) These lines of evidence make it tempting to speculate that M-b-CyD and DM-b-CyD dominantly interact with cholesterol-rich lipid rafts. However, the possibility that DM-b-CyD interacts with sphingolipids-rich rafts cannot be ruled out since DM-b-CyD lowered the level of NBD-sphingomyelin of cell surface (Fig.  5) . Therefore, elaborate study is further required to address this possibility. Anyhow, the type of morphological changes in RRBC induced by CyDs may be associated with the subclass of lipid rafts, i.e., the morphological changes from discocyte to echinocyte and that to stomatocyte are associated with cholesterol-rich lipid rafts and sphingolipid-rich lipid rafts, respectively.
Apart from the safety viewpoint of CyDs, it is well known that lipid rafts of RBC membranes are involved in an infection of a number of vacuolar pathogens, including the malaria parasite Plasmodium falciparum, although erythrocytes are nonendocytotic. 44, 45) Recently, Ziegler et al. 46) reported that antiplasmodial activity of triterpene betulinic acid and its analogues may be caused by modifications of lipid rafts through the incorporation of the compounds into the lipid bilayers of erythrocytes. Therefore, it is possible to assume that M-b-CyD and DM-b-CyD have antiplasmodial activity as well.
In conclusion, we revealed that M-b-CyD and DM-b-CyD had strong hemolytic activity rather than b-CyD. M-b-CyD and DM-b-CyD were found to induce the morphological changes from discocyte to echinocyte through the selective extraction of cholesterol and proteins, possibly from cholesterol-rich lipid rafts of RRBC membranes. These results will provide useful information for the pharmaceutical and cell biological applications of methylated b-CyD derivatives.
